A Review of 2002
Oral UF Heparin: Established Phase III safety database for EMISPHERE® delivery agent, SNAC
Oral LMW Heparin: Initiated and completed a Phase I study
Oral Insulin: Completed 90 day toxicology studies
Oral Insulin: Completed fed Type II patient study
Oral PTH: Completed first Phase I trial
Oral Cromolyn: Data from preliminary patient studies in allergy patients
Presented full analysis of Phase III “PROTECT” Trial at ASH
Solid oral UF Heparin: Phase I data from tablets and capsules
Oral Salmon Calcitonin: Completion of Phase II enrollment by NVS
Oral rhGH: Completed Phase I dosing of EMISPHERE® delivery agent and drug combination